Provided by Tiger Fintech (Singapore) Pte. Ltd.

Eli Lilly

713.71
-1.4900-0.21%
Post-market: 714.000.2900+0.04%19:59 EDT
Volume:2.64M
Turnover:1.88B
Market Cap:676.41B
PE:60.95
High:719.64
Open:710.00
Low:709.00
Close:715.20
Loading ...

Haya Therapeutics: Funding Round Led by Sofinnova Partners & Earlybird Venture Capital, Participation From Eli Lilly & Company, Athos & Others

THOMSON REUTERS
·
08 May

BRIEF-Eli Lilly Announces Transitions In Executive Leadership

Reuters
·
08 May

Eli Lilly and Co - Patrik Jonsson Appointed Evp and President, Lilly International

THOMSON REUTERS
·
08 May

Lilly Announces Transitions in Executive Leadership

THOMSON REUTERS
·
08 May

Press Release: Lilly announces transitions in executive leadership

Dow Jones
·
08 May

BUZZ-US drugmakers fall on report of Trump plan to lower drug prices

Reuters
·
08 May

Trump Is Threatening Big Pharma With Tariffs. Tax Changes Might Work Better. -- Heard on the Street -- WSJ

Dow Jones
·
07 May

TRADING DAY-Absent tariff clarity, nerves fray

Reuters
·
07 May

Eli Lilly & Co. Stock Falls 5.6%, Underperforms Competitors

Dow Jones
·
07 May

Drug Stocks Hit By D.C. Developments -- Market Talk

Dow Jones
·
07 May

Stock Track | Eli Lilly Plummets 5.03% on Tariff Threats, CVS Decision, and Lowered Profit Outlook

Stock Track
·
07 May

Stock Track | Eli Lilly Plummets 5.03% Amid Trump's Pharma Tariff Threat and Lowered Profit Outlook

Stock Track
·
07 May

Eli Lilly (LLY) Raises Dividend by 15%, Maintains Shareholder Payout for 55th Consecutive Year

TIPRANKS
·
06 May

BUZZ-Drugmakers fall as Trump signals announcement on medicine costs

Reuters
·
06 May

US STOCKS-Wall Street declines after Trump's latest tariff threats

Reuters
·
06 May

Eli Lilly Stock Slips on Outlook. Is It Time to Buy the Dip?

Motley Fool
·
06 May

Pharma Stocks Sink as Trump Sets Pharma Tariffs Deadline. Moderna Down 5%; Merck, Eli Lilly Down over 2%

Dow Jones
·
06 May

BRIEF-Alchemab Therapeutics Signs Landmark $415M Licensing Agreement For ATLX-1282 With Eli Lilly And Company

Reuters
·
06 May

Eli Lilly Keeps Quarterly Dividend at $1.50 a Share, Payable June 10 to Shareholders of Record as of May 16

MT Newswires Live
·
06 May

Eli Lilly and Co - Declares Q2 2025 Dividend of $1.50 per Share

THOMSON REUTERS
·
06 May